FAM30A
Putative uncharacterized protein FAM30A
Also known as: FA30A_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for FAM30A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
134 residues, UniProt reviewed canonical sequence.
>Q9NZY2|FAM30A
1 MGTLQGAALR SRERPSWPQE THGHRERTEE GCAVAAFSAD ALRTGGQELE QTGLRPKAGA
61 PPMPDLLGHR ICTDIGKGWR MDGGRTCSCS SFCRCPERGA RRSSPDAPGL ALDFPLLLDL
121 LWHLCSWTSQ PLELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM30A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM30A as an antibody target. Whether an autoantibody or antibody against FAM30A could matter depends on whether native FAM30A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM30A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM30A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...